Bifidobacterium animalis subsp. lactis HN019 has antimicrobial activity against endodontic pathogens in vitro

The aim of the present study was to evaluate, in vitro, the antimicrobial activity of the probiotic Bifidobacterium animalis subsp. lactis HN019, through the well technique, against 10 microorganisms can be found involved in endodontic infections. The antimicrobial activity of the probiotic was performed on Streptococcus mutans , Streptococcus sobrinus , Lacticaseibacillus casei , Enterococcus faecalis , Staphylococcus aureus , Candida albicans , Porphyromonas gingivalis , Porphyromonas endodontalis , Fusobacterium nucleatum and Prevotella intermedia . For the control group, it was used non-pathogenic bacteria Escherichia coli , Saccharomyces cerevisiae , and Kocuria rizhopilla . After 48 to 72 h of incubation of the petri dishes containing the culture medium, the microorganism strains, and the probiotic, the plates were examined to assess the uniformity of microbial growth, presence of contaminants, and the halo of inhibition. After visual inspection, the reading of the halo of inhibition was performed with the aid of a digital caliper using a reflected light source to illuminate the inverted plate on a black, opaque background after removing the cap. Thus, 3 values were obtained from each bacterial inoculum, which were added and divided by three to obtain the average of the values. The results of the in vitro study demonstrated that the probiotic B. animalis subsp. lactis HN019 promoted the inhibition of all strains of the pathogens evaluated, with the exception of Candida albicans , demonstrating antimicrobial activity on these microorganisms.